Creo Medical Group PLC (AIM:CREO), a pioneer in surgical endoscopy, has entered into a strategic collaboration with Khalifa University of Science and Technology in Abu Dhabi, investors were told.
Designed to capitalise on Creo's extensive intellectual property portfolio and Khalifa University's research expertise, the tie-up will initially focus on addressing healthcare challenges specific to the UAE, as well as the broader Middle East and North Africa (MENA) region.
It comes on the heels of the UK company's recent successful surgical procedures in the UAE.
Craig Gulliford, CEO of Creo Medical, said: "Creo has broad and deep IP that underpins its Kamaptive electrosurgical advanced energy and non-thermal plasma sterilisation technology used in current products as well as offering significant potential for future products and treatments.
"As part of our strategy, we are driven to exploit our IP either directly or in partnership with third-parties, as shown by our Robotic Assisted Surgery collaborations.
"Khalifa University is a research-intensive organisation with a similar drive to develop and commercially exploit leading technologies, at scale and on a global basis.
"The combination of Creo's people, technology and IP with Khalifa University's teams, technologies, facilities and resources represents a great opportunity for both organisations to advance and commercialise incremental technology and products and enhance research profiles internationally."